Skip to main content

Advertisement

Fig. 3 | BMC Cancer

Fig. 3

From: Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphoma

Fig. 3

Selected differentially bound genes derived from MYC and H3K4me3 ChIP-Seq experiments. Twenty selected target genes with a highest Log Fold Change value obtained from differential binding analysis for each pairwise comparison (BL_vs_DLBCL; BL_vs_DLBCLneg; BL_vs_DLBCLpos; DLBCLpos_vs_DLBCLneg). Restriction to 2000 bp upstream of transcriptional start site; IDR < 0.1 and p-value < 0.05

Back to article page